Urinary and serum titanium: Assessment as an indicator of exposure to ammonium citratoperoxotitanate (IV) and its influence on renal function

Biological Trace Element Research

Volumn 110, Issue 2, 2006, Pages 119-131

  Nakasuji, Kazuo ^a   Usuda, Kan ^a   Kawasaki, Takashi ^a   Dote, Emi ^a   Hayashi, Satsuki ^a   Mitsui, Go ^a   Adachi, Kazuya ^a   Fujihara, Michiko ^a   Shimbo, Yukari ^a   Kono, Koichi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Ammonium citratoperoxotitanate (IV); ICP AES; Photocatalyst; Renal toxicity; Serum titanium; Urinary titanium

Indexed keywords

AMMONIUM CITRATOPEROXOTITANATE; TITANIUM; TITANIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CONTROLLED STUDY; DOSE RESPONSE; DRUG CONJUGATION; DRUG DETERMINATION; DRUG HYPERSENSITIVITY; DRUG SOLUBILITY; DRUG SYNTHESIS; ENVIRONMENTAL EXPOSURE; GASTROINTESTINAL ABSORPTION; HALF LIFE TIME; KIDNEY FUNCTION; MALE; METAL BINDING; NEPHROTOXICITY; NONHUMAN; OCCUPATIONAL TOXICOLOGY; PHOTOCATALYSIS; RAT; URINARY EXCRETION; URINE LEVEL;

ACETYLGLUCOSAMINIDASE; ALPHA-GLOBULINS; ANIMALS; ENVIRONMENTAL EXPOSURE; GLOMERULAR FILTRATION RATE; KIDNEY; LETHAL DOSE 50; MALE; ORGANOTECHNETIUM COMPOUNDS; RATS; RATS, WISTAR; TIME FACTORS; TITANIUM;

ANIMALIA; RATTUS NORVEGICUS;

EID: 33745726078     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:110:2:119     Document Type: Article

References (32)

1. M. Kakihana, K. Tomita, V. Petrykin, M. Tada, S. Sasaki, and Y. Nakamura, Chelating of titanium by lactic acid in the water-soluble diammonium tris (2-hydroxypropionato) titanate(IV), Inorg. Chem. 43, 4546-4548 (2004).
2. O. A. Kholdeeva, T. A. Trubitsina, R. I. Maksimovskaya, et al., First isolated active titanium peroxo complex: characterization and theoretical study, Inorg. Chem. 43, 2284-2292 (2004).
3. 2-based thioether oxidation, Inorg. Chem. 39, 3828-3837 (2000).
4. 2: a surface spectroscopic approach, Environ. Pollut. 120, 415-422 (2002).
5. 2 photocatalyst, Chemosphere 48, 437-444 (2002).
6. W. Wang, L. W. Chiang, and Y. Ku, Decomposition of benzene in air streams by UV/TiO(2) process, J. Hazard Mater. 101, 133-146 (2003).
7. A. Harstrick, H. J. Schmoll, G. Sass, H. Poliwoda, and T. Rustum, Titanocendichloride activity in cisplatin and doxorubicin-resistant human ovarian carcinoma cell lines, Eur. J. Cancer 29, 1000-1002 (1993).
8. F. Caruso and M. Rossi, Antitumor titanium compounds, Mini. Rev. Med. Chem. 4, 49-60 (2004).
9. E. Melendez, Titanium complexes in cancer treatment, Crit. Rev. Oncol. Hematol. 42, 309-315 (2002).
10. A Korfel, M. E. Scheulen, H. J. Schmoll, et al., Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors, Clin. Cancer Res. 4, 2701-2708 (1998).
11. G. Lummen, H. Sperling, H. Luboldt, T. Otto, and H. Rubben, Phase II trial of titanocene dichloride in advanced renal-cell carcinoma, Cancer Chemother. Pharmacol. 42, 415-417 (1998).
12. K. Mross, P. Robben-Bathe, L. Edler, et al., Phase I clinical trial of a day-1, -3, -5 every 3 weeks schedule with titanocene dichloride (MKT 5) in patients with advanced cancer. (Phase I Study Group of the AIO of the German Cancer Society), Onkologie 23, 576-579 (2000).
13. L. G. Harris and R. G. Richards, Staphylococcus aureus adhesion to different treated titanium surfaces, J. Mater. Sci. Mater. Med. 15, 311-314 (2004).
14. J. Parvizi, E. Wickstrom, A. R. Zeiger, et al., Titanium surface with biologic activity against infection, Clin. Orthop. Related Res. 429, 33-38 (2004).
15. K. P. Kuhn, I. F. Chaberny K. Massholder, et al., Disinfection of surfaces by photocatalytic oxidation with titanium dioxide and UVA light, Chemosphere 53, 71-77 (2003).
16. B. S. Richards, S. F. Rowlands, A. Ueranatasun, J. E. Cotter, and C. B. Honsberg, Potential cost reduction of buried-contact solar cells through the use of titanium dioxide thin films, Solar Energy 76, 269-276 (2004).
17. M. Niemela, P. Peramaki, and J. Piispanen, Microwave sample-digestion procedure for determination of arsenic in moss samples using electrothermal atomic absorption spectrometry and inductively coupled plasma mass spectrometry Anal. Bioanal. Chem. 375, 673-678 (2003).
18. A. Sahuquillo, R. Rubio, J. M. Ribo, E. Ros, and M. Vela, Application of focused-microwave wet digestion to the determination of trace metals in human gallstones by ICP/AES, J. Trace Elements Med. Biol. 14, 96-99 (2000).
19. M. Krachler, H. Radner, and K. J. Irgolic, Microwave digestion methods for the determination of trace elements in brain and liver samples by inductively coupled plasma mass spectrometry, Anal. Bioanal. Chem. 355, 120-128 (1996).
20. I. A. Bergdahl, A. Schutz, L. Gerhardsson, A. Jensen, and S. Skerfving, Lead concentrations in human plasma, urine and whole blood, Scand. J. Work Environ. Health 23, 359-363 (1997).
21. Z. Karpas, L. Halicz, J. Roiz, et al., Inductively coupled plasma mass spectrometry as a simple, rapid, and inexpensive method for determination of uranium in urine and fresh water: comparison with LIF, Health Phys. 71, 879-885 (1996).
22. P. Allain, Y. Mauras, C. Douge, L. Jaunault, T. Delaporte, and C. Beaugrand, Determination of iodine and bromine in plasma and urine by inductively coupled plasma mass spectrometry, Analyst 115, 813-815 (1990).
23. J. Edel, E. Marafante, and E. Sabbioni, Retention and tissue binding of titanium in the rat, Hum. Toxicol. 4, 177-185 (1985).
24. L. Messori, P. Orioli, V. Banholzer, I. Pais, and P. Zatta, Formation of titanium(IV) transferrin by reaction of human serum apotransferrin with titanium complexes, FEBS Lett. 442, 157-161 (1999).
25. S. Artik, K. Haarhuis, X. Wu, J. Begerow, and E. Gleichmann, Tolerance to nickel: oral nickel administration induces a high frequency of anergic T cells with persistent suppressor activity, J. Immunol. 167, 6794-6803 (2001).
26. S. G. Adler, A. H. Cohen, and R. J. Glassock, Secondary glomerular diseases, in The Kidney, B. M. Brenner, et al., eds., WB Saunders, Philadelphia, pp. 1498-1596 (1996).
27. P. Boffetta, V. Gaborieau, L. Nadon, M. F. Parent, E. Weiderpass, and J. Siemiatycki, Exposure to titanium dioxide and risk of lung cancer in a population-based study from Montreal, Scand. J. Work Environ. Health 27, 227-232 (2001).
28. P. Boffetta, A. Soutar, J. W. Cherrie, et al., Mortality among workers employed in the titanium dioxide production industry in Europe, Cancer Causes Control 15, 697-706 (2004).
29. J. P. Fryzek, B. Chadda, D. Marano, et al., A cohort mortality study among titanium dioxide manufacturing workers in the United States, J. Occup. Environ. Med. 45, 400-409 (2003).
30. S. M. Paulsen, L. B. Nanney, J. B. Lynch, Titanium tetrachloride: an unusual agent with the potential to create severe burns, J. Burn Care Rehabil. 19, 377-381 (1998).
31. D. K. Chitkara and B. J. McNeela, Titanium tetrachloride burns to the eye, Br. J. Ophthalmol. 76, 380-382 (1992).
32. T. Park, R. DiBenedetto, K. Morgan, R. Colmers, and E. Sherman, Diffuse endobronchial polyposis following a titanium tetrachloride inhalation injury, Am. Rev. Respir. Dis. 130, 315-317 (1984).